Published: April 21st 2025 | Updated: August 27th 2025
Global Burden of Atopic Dermatitis in Older Adults Underestimated and Expected to Rise Substantially by 2050
Published: June 6th 2025 | Updated: August 27th 2025
Long-Term Roflumilast Data Show Durable Efficacy in Young Children and Adults with Atopic Dermatitis
Published: June 6th 2025 | Updated: August 27th 2025
Patient Survey Highlights Importance of Itch Relief, Personalized Guidance in Atopic Dermatitis Treatment
Published: June 6th 2025 | Updated: August 27th 2025
Real-World Abrocitinib Study Shows Most Patients Maintain Consistent Dosing in Atopic Dermatitis Treatment
Published: June 6th 2025 | Updated: August 27th 2025
Roflumilast Cream 0.15% Demonstrates Safety, Tolerability in Individuals With Atopic Dermatitis With Prior Treatment Failures
Published: June 6th 2025 | Updated: August 27th 2025
Lebrikizumab Maintains Deep Response, QoL Through 3 Years in Atopic Dermatitis Extension Study